Stay updated on Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The ClinicalTrials.gov revision identifier also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:07:26.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page; the footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:11:20.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 error, replacing the usual study details with a forbidden page. This prevents users from viewing the trial's overview, eligibility criteria, and locations, which are central to the page's function.
    Difference
    19%
    Check dated 2026-09-22T22:27:34.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, representing a new page version. This update likely includes internal adjustments or bug fixes rather than user-visible content changes on the study details page.
    Difference
    0.0%
    Check dated 2026-09-15T21:52:30.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous revision tag. This reflects a minor build/update of the page instead of changes to study data or eligibility information.
    Difference
    0.0%
    Check dated 2026-09-01T17:47:24.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    A funding note, '2017 ( U.S. NIH Grant/Contract )', was added under the study identifiers to indicate NIH funding. This update provides funding context alongside other identifiers in the study record.
    Difference
    0.0%
    Check dated 2026-08-25T19:50:49.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.